Introduction {#s1}
============

The Target of Rapamycin Complex 1 (TORC1) plays a pivotal role in controlling cell growth in probably all eukaryotic organisms. It operates by integrating upstream signals such as growth factors (GFs) and nutrients to modulate, by phosphorylation, multiple downstream effectors, mostly proteins involved in anabolic processes (e.g. protein synthesis, ribosome biogenesis) or catabolic processes (e.g. autophagy, bulk endocytosis of plasma membrane transporters) ([@bib23]; [@bib59]; [@bib64]). The central role of TORC1 in regulating cell growth is illustrated by the many reported cases of mTORC1 dysfunction associated with diseases including cancers ([@bib15]; [@bib64]).

In human cells, GFs and amino acids are key signals of mTORC1 regulation. GFs act through activation of Rheb, a GTPase present at the lysosomal membrane that stimulates mTORC1 activity ([@bib14]; [@bib80]). Amino acids such as leucine and arginine act via a complex of two GTPases, namely RagA or B and RagC or D, to promote recruitment of mTORC1 to the lysosome, where it is activated by Rheb. The heterodimeric Rag GTPase complex recruits mTORC1 to the lysosome when RagA/B is bound to GTP and RagC/D to GDP ([@bib39]; [@bib63]). The activity of GTPases is typically modulated by GTPase Activating Proteins (GAPs) and Guanine nucleotide Exchange Factors (GEFs). Recent studies have aimed to identify these GAPs and GEFs and their upstream regulators and to better understand how these factors are controlled in response to variations in the cytosolic concentrations of amino acids and/or to their transport across the plasma or lysosomal membrane ([@bib23]; [@bib59]; [@bib64]). Importantly, Sestrin and Castor proteins have recently been found to act, respectively, as cytosolic leucine and arginine sensors. When bound to their specific amino acids, these sensor proteins lose the ability to inhibit GATOR2, a negative modulator of the GATOR1 GAP complex which inhibits RagA/B, and this results in TORC1 activation ([@bib79]). Specific lysosomal amino acid transporters and the V-ATPase complex also contribute importantly to mTORC1 control ([@bib22]; [@bib82]). All this illustrates the complexity of the mechanisms through which amino acids regulate mTORC1 activity.

The TOR kinase that is part of TORC1 was originally identified in yeast, after isolation of dominant *TOR* mutations conferring resistance to rapamycin (Rap) ([@bib32]; [@bib42]). The protein components of TORC1, the RagA/B and C/D proteins, and their upstream GATOR-type regulatory complexes also exist in yeast ([@bib29]; [@bib42]). For instance, RagA/B and RagC/D correspond, respectively, to the yeast Gtr1 and Gtr2 proteins, which are part of a vacuole-associated complex (EGO) ([@bib13]) similar to the Rag-binding Ragulator of human cells ([@bib62]). When cells are grown in nutrient-rich medium, yeast TORC1 is active and stimulates by phosphorylation a wide variety of proteins. It notably stimulates the Sch9 kinase ([@bib73]) under conditions promoting anabolic functions and cell growth. Active TORC1 also inhibits the Tap42-PP2A phosphatase, which stimulates autophagy, stress resistance, and nitrogen (N) transport and utilization ([@bib42]). In contrast, TORC1 is inhibited in N-starved and Rap-treated cells, so that anabolic processes, including protein synthesis, are inhibited and cell responses such as autophagy, bulk endocytosis of transporters, utilization of secondary N sources, and stress resistance are stimulated ([@bib29]; [@bib42]). One Tap42-PP2A target protein is the protein kinase Npr1 (Nitrogen permease reactivator 1), which is phospho-inhibited when TORC1 is active ([@bib65]). Once Npr1 is inhibited, various permeases of nitrogenous compounds undergo intrinsic inactivation ([@bib2]; [@bib3]) or downregulation via ubiquitylation, endocytosis, and degradation ([@bib44]; [@bib46]).

Stimulation of TORC1 activity in yeast is usually monitored by visualizing the degree of Sch9 and/or Npr1 kinase phosphorylation. Sch9 and Npr1 are moderately phosphorylated in cells grown on a poor N source such as proline, but hyperphosphorylated upon addition of a preferential N source such as glutamine (Gln) or NH~4~^+^ ([@bib65]; [@bib69]; [@bib73]). In a study using Sch9 phosphorylation as readout, addition of any amino acid to proline-grown cells was found to result in rapid but transient Rag/Gtr-dependent TORC1 activation, whereas longer term TORC1 activation was observed only upon addition of an N source supporting optimal growth, for example Gln or NH~4~^+^, and it appeared not to depend on the Rag GTPases ([@bib69]). Furthermore, sustained activation of TORC1 in response to NH~4~^+^ is impaired in mutant cells lacking the glutamate dehydrogenases involved in assimilation of NH~4~^+^ into amino acids ([@bib17]; [@bib46]). The upstream signals and molecular mechanisms involved in activation of yeast TORC1 in response to amino acid uptake and/or assimilation remain poorly known. For instance, although Gln behaves as a key signal for sustained TORC1 stimulation ([@bib7]; [@bib69]), no Gln sensor has been identified to date, and yeast seems to lack Sestrin and Castor proteins. Furthermore, no study has evidenced any particular role of vacuolar amino acid transporters in TORC1 regulation. The yeast leucyl-tRNA synthetase is reported to play a role in sensing balanced levels of isoleucine, leucine, and valine and to act as a GEF for Gtr1 ([@bib4]), whereas the equivalent mammalian enzyme is proposed to control mTORC1 as a GAP for RagD ([@bib28]). On the basis of current knowledge, it would thus seem that the upstream signals and mechanisms controlling TORC1 according to the N or amino acid supply conditions might differ significantly between yeast and human cells.

The present study began with an unexpected observation regarding the uptake of β-alanine into yeast cells: this amino acid, which cannot be used as an N source (i.e. it is not a source of amino acids), stimulates TORC1 activity. Analysis of this effect has revealed that the general signal triggering Rag/Gtr-dependent activation of TORC1 in response to amino acid uptake is the influx of H^+^ coupled to transport via H^+^/amino-acid symporters. We further show that the Pma1 H^+^-ATPase establishing the H^+^ gradient at the plasma membrane is essential to this TORC1 activation, and suggest that Pma1 modulates TORC1 via signaling.

Results {#s2}
=======

Uptake of β-alanine via the Gap1 permease causes Rag/Gtr-dependent TORC1 activation without increasing internal pools of amino acids {#s2-1}
------------------------------------------------------------------------------------------------------------------------------------

In cells growing under poor N supply conditions (e.g. in a medium containing proline as sole N source), the yeast general amino acid permease Gap1 is active and stable at the plasma membrane. Under these conditions, TORC1 is only moderately active ([@bib65]). Activation of TORC1 upon NH~4~^+^ uptake and assimilation into amino acids triggers Gap1 ubiquitylation, followed by its endocytosis and degradation in the vacuole ([@bib46]). Thanks to isolation of a Gap1 mutant insensitive to this TORC1-dependent ubiquitylation, we have shown that substrate transport by Gap1 can also trigger Ub-dependent endocytosis and degradation of this transporter ([@bib21]). This type of control, shared with other transporters of fungal and non-fungal species, probably enables cells to avoid excess uptake of external compounds ([@bib25]). To further investigate, without interference from the TORC1-dependent pathway, the mechanism of transport-elicited Gap1 ubiquitylation we sought to identify a Gap1 amino acid substrate unable to activate TORC1. We focused on beta-alanine (β-ala) and confirmed its reported status as a Gap1 substrate ([@bib68]) by comparing the uptake of \[^14^C\]-β-ala (0.5 mM) in proline-grown wild-type and *gap1∆* mutant cells ([Figure 1A](#fig1){ref-type="fig"}). β-Ala, however, cannot sustain growth when used as sole N source, that is it cannot serve as a source of amino acids ([Figure 1A](#fig1){ref-type="fig"}). This contrasts with 4-aminobutyrate (GABA), an amino acid differing from β-ala by a single additional CH~2~ group ([Figure 1A](#fig1){ref-type="fig"}) and whose catabolism depends on a specific GABA transaminase ([@bib1]). We thus tested whether β-ala transport by Gap1 triggers ubiquitylation and downregulation of the transporter. This proved to be the case, as addition of β-ala (0.5 mM) caused the appearance, above the immunodetected Gap1 signal, of two slowly migrating bands that were not observed with the non-ubiquitylable Gap1(K9R,K16R) mutant ([Figure 1B](#fig1){ref-type="fig"}). Upon β-ala addition, furthermore, Gap1 initially present at the cell surface underwent endocytosis and targeting to the vacuole, whereas Gap1(K9R,K16R) remained stable at the plasma membrane ([Figure 1C](#fig1){ref-type="fig"}). An inactive Gap1 mutant (Gap1-126) ([@bib21]) failed to be ubiquitylated and downregulated upon β-ala addition ([Figure 1B and C](#fig1){ref-type="fig"}). These results are those expected if β-ala elicits Gap1 ubiquitylation specifically via the transport-elicited pathway. Yet we sought to make sure that β-ala does not activate TORC1. To our surprise, addition of β-ala to proline-grown cells caused a typical manifestation of TORC1 activation: a Rap-sensitive reduction of the electrophoretic mobility of HA-tagged Npr1, indicative of increased phosphorylation via TORC1 ([@bib46]; [@bib65]) ([Figure 1D](#fig1){ref-type="fig"}). β-Ala similarly caused a Rap-sensitive increase in the phosphorylation of Sch9 kinase residue Thr737 ([Figure 1E](#fig1){ref-type="fig"}), a known TORC1 target ([@bib73]). It thus seemed that activation of TORC1, largely impaired in the *gap1∆* mutant ([Figure 1D and E](#fig1){ref-type="fig"}), could contribute to the observed β-ala-induced downregulation of Gap1. This assumption was confirmed in additional experiments ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Gap1-mediated uptake of β-ala thus results in TORC1 activation. We therefore hypothesized that, although β-ala cannot be used as an N source, it might be converted to certain amino acids capable of stimulating TORC1. β-Ala uptake, however, was found not to increase the intracellular concentrations of individual amino acids, measured in cell extracts, apart from that of β-ala itself ([Figure 1F](#fig1){ref-type="fig"}). We next tested whether this β-ala-induced activation of TORC1 involves the Rag A/B and C/D GTPases, encoded by the *GTR1* and *GTR2* genes, respectively. Increased phosphorylation of Npr1 upon β-ala addition was indeed impaired in *gtr1∆ gtr2∆* mutant cells ([Figure 1G](#fig1){ref-type="fig"}), and this effect was not due to reduced uptake of β-ala ([Figure 1H](#fig1){ref-type="fig"}). We conclude that Gap1-mediated uptake of β-ala elicits TORC1 activation via the Rag GTPases, and that this effect is not due to conversion of intracellular β-ala to other amino acids.

![Uptake of β-alanine via the Gap1 permease causes Rag/Gtr-dependent TORC1 activation without increasing the internal pools of amino acids.\
(**A**) Top. Wild-type (w--t) and *gap1Δ* cells were grown on Gluc Pro medium and \[^14^C\]-β-ala (0.5 mM) was added to the medium before measurement of the incorporated radioactivity at various times. Bottom. w-t cells were grown for 4 days on solid minimal medium without any N source or with GABA (0.5 mM) or β-ala (0.5 mM) as sole N source. (**B**) *gap1Δ* cells expressing, from plasmids, a gene encoding GFP-fused Gap1, Gap1(K9R-K16R), or Gap1-126 were grown on Gal Pro medium. Glucose was added for 30 min to stop Gap1 neosynthesis prior to addition of β-ala (0.5 mM) for 4 min. Crude cell extracts were prepared and immunoblotted with anti-GFP and anti-Pma1 antibodies. (**C**) Fluorescence microscopy analysis of the cells in 1B. Cells were grown on Gal Pro medium. Glucose was added for 1.5 hr to stop Gap1 neosynthesis, and β-ala (0.5 mM) was added for 30 min or 1 hr. CMAC staining (blue) was used to highlight the vacuole. (**D**) Top. w-t and *gap1Δ* cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and at various times after addition of β-ala (0.5 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. Bottom. Same as in the top panel, except that w-t cells were collected before and 4 min after addition of β-ala (0.5 mM). Rap was added to half of the culture for 30 min, before addition of β-ala (0.5 mM). (**E**) Top. w-t and *gap1Δ* cells were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of β-ala (0.5 mM). Crude extracts were prepared and immunoblotted with anti-(**P**) T^737^-Sch9 and anti-Sch9~Total~ antibodies. Bottom. Same as in panel G, except that w-t cells were collected before and 4 min after addition of β-ala (0.5 mM). Half of the culture was pretreated with Rap for 30 min. (**F**) w-t cells were grown on Gluc Pro medium. Cell extracts were prepared before and 30 min after addition of β-ala (0.5 mM) and used to measure amino acid pools as described under Materials and methods. The presented data are means ±SD of two independent experiments. (**G**) w-t and *gtr1Δ gtr2Δ* cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of β-ala (0.5 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. (**H**) Cells as in G were grown on Gluc Pro medium. \[^14^C\]-β-ala (0.5 mM) was added to the medium before measuring the incorporated radioactivity at various times.](elife-31981-fig1){#fig1}

Uptake of β-ala via the endogenous Put4 or the heterologous HcGap1 permease also promotes TORC1 activation {#s2-2}
----------------------------------------------------------------------------------------------------------

Gap1 has been reported to be a 'transceptor', that is a protein combining the properties of transporters and receptors, capable of activating protein kinase A (PKA) in a cAMP-independent manner ([@bib12]). According to this model, conformational changes of Gap1, triggered by binding and/or transport of amino acids, would stimulate a PKA-targeting signaling pathway ([@bib66]). We thus hypothesized that this transceptor function of Gap1 might also promote TORC1 activation in a Rag/Gtr-dependent manner. This hypothesis is potentially supported by a previous report that Gap1 interacts with Gtr2 ([@bib19]). An alternative view is that β-ala entering cells through Gap1 might be detected by a cytosolic amino acid sensor capable of promoting TORC1 activation. To explore these possibilities, we tested whether β-ala uptake via another permease might also activate TORC1. Confirming a previous prediction ([@bib24]), we found the high-affinity proline permease Put4 also to catalyze β-ala transport. This contribution of Put4 was visible at least in proline-free media, such as a medium where the sole N source was urea (another poor N source). Under these conditions, the *gap1∆* mutant displayed residual uptake of β-ala (2 mM), and this uptake was abolished in the *gap1∆ put4∆* mutant ([Figure 2A](#fig2){ref-type="fig"}). Importantly, this Put4-dependent β-ala uptake was associated with a Rap-sensitive hyperphosphorylation of Npr1 ([Figure 2B](#fig2){ref-type="fig"}). We next expressed in the *gap1∆* mutant a heterologous amino acid transporter known to be active in *S. cerevisiae*, namely the Gap1 permease of the fungus *Hebeloma cylindrosporum* ([@bib78]). HcGap1 shares \~ 30% sequence identity with Gap1 and Put4. In proline-grown *gap1∆* cells, HcGap1 restored high β-ala uptake activity, roughly similar to that conferred by Put4 to urea-grown cells ([Figure 2C](#fig2){ref-type="fig"}). Remarkably, this uptake of β-ala was also associated with Rap-sensitive hyperphosphorylation of Npr1 ([Figure 2D](#fig2){ref-type="fig"}). In conclusion, transport of β-ala via endogenous Gap1 and/or Put4 or via the heterologous HcGap1 permease elicits TORC1 activation. Although these observations do not rule out the possibility that all three tested permeases might function as transceptors, they seem to favor the view that intracellular β-ala itself, or the process of its transport across the plasma membrane, stimulates TORC1 activity.

![Uptake of β-ala via the endogenous Put4 or the heterologous HcGap1 permease also promotes TORC1 activation.\
(**A**) w-t, *gap1Δ*, and *gap1Δ put4Δ* cells were grown on Gluc urea medium. \[^14^C\]-β-ala (0.1 or 2 mM) was added to the medium before measuring the incorporated radioactivity at various times. (**B**) Top. Cells as in A expressing HA-Npr1 from a plasmid were grown on Gluc urea medium. Cells were collected before and 4 and 10 min after addition of β-ala (0.1 or 2 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. Bottom. Same as in panel B except that *gap1Δ* cells were also collected 30 min after Rap treatment. (**C**) w-t and *gap1Δ* cells expressing or not HcGap1 from a plasmid were grown on Gluc Pro medium. \[^14^C\]-β-ala (0.5 or 2 mM) was added to the medium before measuring the incorporated radioactivity at various times. (**D**) Top. w-t and *gap1Δ* cells expressing HA-Npr1 and *gap1Δ* cells co-expressing HcGap1 and HA-Npr1 from plasmids were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of β-ala (0.5 or 2 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. Bottom. Same as in top panel except that cells were also treated for 30 min with Rap before β-ala addition.](elife-31981-fig2){#fig2}

Uptake of arginine via an endogenous or a heterologous permease stimulates TORC1 even if arginine catabolism is impaired {#s2-3}
------------------------------------------------------------------------------------------------------------------------

Uptake of arginine (Arg) by proline-grown cells is known to be mediated by Gap1 and the arginine-specific permease Can1 ([@bib75]). Consistently, we measured high Arg uptake activity in the wild type and in *gap1∆* and *can1∆* single mutants, but none in the *gap1∆ can1∆* double mutant ([Figure 3A](#fig3){ref-type="fig"}). According to a previous report, Can1, in contrast to Gap1, does not stimulate PKA upon substrate transport ([@bib12]). This suggests that Can1 does not function as a transceptor. We thus sought to determine whether Arg transport via Gap1 or Can1 alone supports TORC1 activation. Arg uptake into wild-type cells was indeed found to induce Rap-sensitive Npr1 hyperphosphorylation ([Figure 3A and B](#fig3){ref-type="fig"}). This response was impaired in the *gtr1∆ gtr2∆* mutant, an effect not due to decreased Arg uptake ([Figure 3B](#fig3){ref-type="fig"}). Arg-elicited TORC1 activation also resulted in Sch9 phosphorylation ([Figure 3C](#fig3){ref-type="fig"}), as previously reported ([@bib69]). Increased phosphorylation of Npr1 upon Arg addition was also detected in *gap1∆* and *can1∆* single mutants, but not in the *gap1∆ can1∆* strain ([Figure 3A](#fig3){ref-type="fig"}). This shows that both permeases can promote Arg-induced TORC1 activation. We next expressed HcGap1 in the *gap1∆ can1∆* strain and found it to restore high Arg uptake ([Figure 3D](#fig3){ref-type="fig"}) associated with Rap-sensitive Npr1 hyperphosphorylation ([Figure 3E](#fig3){ref-type="fig"}). Arginine catabolism requires arginase (Car1) ([@bib75]), so a *car1* mutant fails to grow on Arg as sole N source ([Figure 3F](#fig3){ref-type="fig"}). Arg addition to the *car1* mutant also resulted in Rap-sensitive Npr1 hyperphosphorylation ([Figure 3G](#fig3){ref-type="fig"}). In conclusion, TORC1 is activated upon Arg uptake via the endogenous Gap1 and/or Can1 or the heterologous HcGap1 permease. This activation of TORC1 involves the Rag GTPases and occurs even if Arg is not catabolized.

![Uptake of arginine via an endogenous or a heterologous permease stimulates TORC1 even if arginine catabolism is impaired.\
(**A**) Left. w-t, *gap1Δ*, *can1Δ*, and *gap1Δ can1Δ* cells were grown on Gluc Pro medium. \[^14^C\]-L-Arg (0.5 mM) was added to the medium before measuring the incorporated radioactivity at various times. Right. Cells as in A expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium and collected before and 4 and 10 min after addition of Arg (0.5 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. (**B**) Left top. w-t and *gtr1Δ gtr2Δ* cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of Arg (0.5 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. Left bottom. Same as in panel left top except that half of the culture was treated for 30 min by Rap before addition of Arg. Right. Cells as in left panels although not expressing HA-Npr1 were grown on Gluc Pro medium. \[^14^C\]-L-Arg (0.5 mM) was added to the medium before measuring the incorporated radioactivity at various times. (**C**) w-t cells were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of Arg (0.5 mM). Crude extracts were prepared and immunoblotted with anti-(**P**) T^737^-Sch9 and anti-Sch9~Total~ antibodies. (**D**) w-t and *gap1Δ can1Δ* cells expressing or not HcGap1 from a plasmid were grown on Gluc Pro medium. \[^14^C\]-L-Arg (0.5 or 1 mM) was added to the medium before measurement of the incorporated radioactivity at various times. (**E**) Top. w-t and *gap1Δ can1Δ* cells expressing HA-Npr1 from plasmid, and *gap1Δ can1Δ* cells co-expressing HcGap1 and HA-Npr1 from plasmids, were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of Arg (0.5 or 1 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. Bottom. Same as in top panel except that half of the culture was treated for 30 min with Rap before addition of Arg. (**F**) Left. w-t and *car1* mutant cells were grown on solid minimal medium with NH~4~^+^ or Arg at a concentration of 2 mM as sole N source. (**G**). *car1* mutant cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of Arg (0.5 mM), and part of the culture was also treated for 30 min with Rap before Arg addition. Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies.](elife-31981-fig3){#fig3}

H^+^ influx coupled to transport promotes rag/Gtr-dependent stimulation of TORC1 {#s2-4}
--------------------------------------------------------------------------------

The simplest way to explain the above observations is that intracellular β-ala and Arg are detected by one or several internal amino acid sensors promoting Rag/Gtr-dependent TORC1 activation. These sensors could, for instance, act like the human Castor and Sestrin proteins, recently shown to function as arginine and leucine sensors, respectively, and to modulate upstream regulators of mTORC1 ([@bib79]). These sensor proteins, however, do not seem to exist in yeast. Furthermore, one would not expect a cytosolic sensor capable of activating TORC1 in response to β-ala. Alternatively, a TORC1-activating signal might arise from a common feature of the permease-mediated Arg and β-ala transport reactions. In yeast, transport by secondary active plasma membrane transporters is coupled to H^+^ influx. This transport is thus driven by the plasma membrane H^+^ gradient established by the Pma1 H^+^-ATPase. We therefore hypothesized that an influx of H^+^ coupled to amino acid uptake might initiate a signal stimulating TORC1 activity. To evaluate this hypothesis, we first checked that the β-ala and Arg transporters tested above are H^+^-symporters. In support of this view, incubation of cells with the FCCP protonophore caused a strong reduction of β-ala uptake via Gap1, Put4, or HcGap1 and of Arg uptake via Gap1, Can1, or HcGap1 ([Figure 4A and B](#fig4){ref-type="fig"}). Furthermore, each permease was rapidly inhibited when the cells were shifted to glucose-free medium ([Figure 4A and B](#fig4){ref-type="fig"}), a condition known to cause rapid inhibition of the Pma1 H^+^-ATPase and thus collapse of the plasma membrane H^+^ gradient ([@bib37]). Hence, as expected, all four permeases analyzed in our study, including HcGap1, behave as H^+^-symporters. We next examined whether active uptake of another metabolite, not present in the growth medium, also elicits Rag/Gtr-dependent TORC1 activation. We chose cytosine, whose uptake via the Fcy2 permease is known to be coupled to H^+^ influx ([@bib56]). Interestingly, addition of cytosine did cause rapid activation of TORC1, as judged by increased Npr1 and Sch9 phosphorylation ([Figure 4C and D](#fig4){ref-type="fig"}). Furthermore, this cytosine-elicited TORC1 activation was largely impaired in the *gtr1∆ gtr2∆* mutant ([Figure 4E](#fig4){ref-type="fig"}). Cytosine can be used as sole N source, and thus as a source of amino acids. Yet in an *fcy1* mutant lacking cytosine deaminase and thus unable to use cytosine as an N source, Npr1 was still phosphorylated upon cytosine addition, unless Rap was also present ([Figure 4F](#fig4){ref-type="fig"}). H^+^-coupled uptake of cytosine thus stimulates TORC1 in a Rag/Gtr-dependent manner, even when the nucleobase is not assimilated into amino acids. This observation is compatible with the proposed view that H^+^ influx is the signal initiating TORC1 stimulation.

![H^+^influx coupled to transport promotes Rag/Gtr-dependent stimulation of TORC1.\
(**A**) The β-ala uptake activities of Gap1 (in w-t cells grown on Gluc Pro medium), Put4 (in *gap1Δ* cells grown on Gluc urea medium), and HcGap1 (in *gap1Δ* cells expressing HcGap1 and grown on Gluc Pro medium), were determined by measuring the initial rate of \[^14^C\]-β-ala incorporation (0.5 mM for Gap1, 2 mM for Put4 and HcGap1) before and after glucose starvation for 5 min or with or without prior incubation with FCCP (20 µM) or its solvent (0.2% EtOH) for 5 min. The presented data are means ± SD of two independent experiments. (**B**) The Arg uptake activities of Gap1 and Can1 (in w-t cells), of Gap1 alone (in *can1Δ* cells), of Can1 alone (in *gap1Δ* cells), and of HcGap1 (in *gap1Δ can1Δ* cells expressing HcGap1 from a plasmid) were determined by measuring the initial rate of \[^14^C\]-L-Arg incorporation (0.5 mM for Gap1 and Can1, 1 mM for HcGap1) as in A. The presented data are means ± SD of two independent experiments. (**C**) w-t cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected 4 min after addition of cytosine (1 mM). Half of the culture was treated with Rap for 30 min before addition of cytosine. Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. (**D**) w-t cells were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of cytosine (1 mM). Crude extracts were prepared and immunoblotted with anti-(**P**) T^737^-Sch9 and anti-Sch9~Total~ antibodies. (**E**) w-t and *gtr1 gtr2Δ* cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of cytosine (1 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. (**F**) Left. w-t and *fcy1* cells were grown on solid medium with NH~4~^+^ or cytosine (2 mM) as sole N source. Right. *fcy1* cells expressing HA-Npr1 were grown on Gluc Pro medium. Cells were collected before and 4 and 10 min after addition of cytosine (0.5 mM). Half of the culture was treated for 30 min with Rap before addition of cytosine. Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. (**G**) w-t (CEN.PK2-1c), *hxtΔ* (EBY.VW4000), and *hxtΔ+FSY1* (**I3**) cells were grown on maltose NH~4~^+^ medium, shifted for 6 hr on EtOH Pro, and \[^14^C\]-D-fructose (2 mM) was added to the medium before measuring the incorporated radioactivity at various times. (**H**) Cells of the w-t and *hxtΔ+FSY1* srains (as in G) were grown on maltose NH~4~^+^ medium. The initial rate of \[^14^C\]-D-fructose incorporation (2 mM), with or without prior incubation with FCCP (20 µM) for 5 min, was then measured. The data are means ±SD of two independent experiments. (**I**) Strains and growth conditions as in G. Cells were collected before and 2, 4 and 10 min after addition of fructose (2 mM). For the I3 strain, half of the culture was treated for 30 min with Rap before addition of fructose. Crude extracts were prepared and immunoblotted with anti-(**P**) T^737^-Sch9 and anti-Sch9~Total~ antibodies.](elife-31981-fig4){#fig4}

To further assess this model, we sought to analyze the activity of TORC1 upon equivalent uptake of the same external compound by either a facilitator or an H^+^-coupled symporter. Hexoses including fructose are known to enter cells via several Hxt transporters that function as facilitators ([@bib76]). Yet particular *S. cerevisiae* strains are reported to also express an H^+^-coupled specific fructose transporter called Fsy1 ([@bib18]; [@bib61]). We thus used the *hxt* null strain, lacking the *HXT1 to −17* and *GAL2* genes and therefore unable to assimilate hexoses ([@bib76]), in which we expressed the *FSY1* gene behind its own promoter, or none hexose transporter gene, and we analyzed in parallel the wild-type (from which the *hxt* null mutant derives) expressing the endogenous Hxt facilitators. The strains were initially grown on maltose as *hxt* null cells can utilize this disaccharide. They were then shifted for a few hours to ethanol because the *FSY1* gene is more highly expressed on this carbon source ([@bib61]). As in previous experiments, the N source was proline. Using these growth conditions, we measured equivalent ^14^C-fructose uptake in Hxt- and Fsy1-expressing cells ([Figure 4G](#fig4){ref-type="fig"}). None significant fructose uptake was detected in the *hxt* null mutant, as expected ([Figure 4G](#fig4){ref-type="fig"}). Furthermore, fructose uptake via Fsy1 was inhibited in the presence of FCCP, but uptake mediated by the Hxt facilitators was not ([Figure 4H](#fig4){ref-type="fig"}). We finally assayed TORC1 activity under these growth and fructose uptake conditions. We observed a Rap-sensitive increase of Sch9 phosphorylation upon fructose uptake by Fsy1-expressing cells. Such a TORC1 activation was observed neither in the wild-type incorporating fructose via the Hxt facilitators nor in the *hxt* null mutant expressing none fructose transporter ([Figure 4I](#fig4){ref-type="fig"}). TORC1 activation in response to fructose uptake thus occurred only when this transport was coupled to H^+^ influx. This result fully supports the view that the H^+^ influx is what generates the TORC1 activation signal.

H^+^ diffusion via a protonophore promotes Rag/Gtr-dependent stimulation of TORC1 {#s2-5}
---------------------------------------------------------------------------------

In all the above experiments, TORC1 thus seems activated in response to the H^+^-influx coupled to a nutrient transport reaction. We next determined whether the sole diffusion of H^+^ via a protonophore such as FCCP might also elicit TORC1 activation. Using a strain stably expressing pHluorin, we first observed that the ionophore caused the cytosolic pH to drop to about 6.1, the pH of the buffered growth medium ([Figure 5A](#fig5){ref-type="fig"}). Remarkably, this rapid acidification of the cytosol coincided with hyperphosphorylation of Npr1, and this response was inhibited by Rap ([Figure 5B](#fig5){ref-type="fig"}). Hence, H^+^ influx mediated by a protonophore also results in TORC1 stimulation. Yet this TORC1 activation, intriguingly, did not lead to increased phosphorylation of Sch9 ([Figure 5C](#fig5){ref-type="fig"}). A likely explanation is that an additional control elicited when the cytosol becomes too acidic (a stressful condition) impedes phosphorylation of Sch9 by activated TORC1. This is in keeping with a previous report that when the cytosolic pH drops to values around 6 (as occurs under glucose starvation or when expression of the Pma1 H^+^-ATPase is repressed), the action of TORC1 on Sch9 is inhibited, whereas nitrogen control of the Gat1 and Gln3 transcription factors via TORC1 remains unaltered ([@bib11]).

![H^+^diffusion via a protonophore promotes Rag/Gtr-dependent stimulation of TORC1.\
(**A**) w-t cells expressing pHluorin (strain ES075) were grown on Gluc Pro medium. The cytosolic pH was monitored for 30 min at regular intervals. FCCP (20 µM) or its solvent (0.2% EtOH) was added at 1 min. (**B**) w-t cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and at various times after addition of FCCP (20 µM) or its solvent (0.2% EtOH). Part of the culture was treated for 30 min with Rap before addition of FCCP. Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. (**C**) w-t cells were grown on Gluc Pro medium. Cells were collected before and at various times after addition of FCCP (20 µM) or its solvent (0.2% EtOH). Crude extracts were prepared and immunoblotted with anti-(**P**) T^737^-Sch9 and anti-Sch9~Total~ antibodies. (**D--G**) w-t and *gtr1 gtr2Δ, seh1Δ, iml1Δ* or *pib2Δ* cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and at various times after FCCP addition (20 µM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies.](elife-31981-fig5){#fig5}

TORC1 activation in response to an FCCP-mediated H^+^ influx, thus visible on immunoblots for HA-Npr1, was largely impaired in the *gtr1∆ gtr2∆* strain ([Figure 5D](#fig5){ref-type="fig"}), indicating that it is Rag/Gtr-dependent. The multisubunit SEACIT complex antagonizes TORC1 by acting as a GAP on the Gtr1 GTPase, and its function is itself negatively controlled by the multisubunit SEACAT complex ([@bib54], [@bib55]). To determine whether these GATOR-like upstream regulators of Gtr1 are involved in H^+^ influx-elicited TORC1 activation, FCCP was added to cells lacking Seh1, a component of the SEACAT complex, or Iml1, a component of the SEACIT complexe ([@bib54], [@bib55]). TORC1 activation was largely impaired in the *seh1∆* mutant ([Figure 5E](#fig5){ref-type="fig"}). In the *iml1∆* mutant, a high basal phosphorylation of HA-Npr1 was detected, as expected, and FCCP did not significantly further increase this phosphorylation, at least during the first minutes after its addition ([Figure 5F](#fig5){ref-type="fig"}). These results indicate that the SEACIT/SEACAT upstream regulators of Gtr1 are involved in H^+^-influx-elicited stimulation of TORC1 activity. We also found the amount of HA-Npr1 to be much reduced in *seh1∆* mutant cells, and a similar effect though less pronounced was observed in the *gtr1∆ gtr2∆* strain ([Figures 1G](#fig1){ref-type="fig"}, [4E](#fig4){ref-type="fig"} and [5D](#fig5){ref-type="fig"}). This suggests that the abundance of HA-Npr1 is influenced by the activation state of TORC1. Furthermore, phosphorylation of HA-Npr1 in the above-analyzed mutants was found to increase after prolonged incubation with FCCP ([Figure 5D, E and F](#fig5){ref-type="fig"}). It thus seems that FCCP stimulates another mechanism of TORC1 activation that does not depend on the Rag/Gtr GTPases. For instance, prolonged incubation with FCCP might promote release of amino acids from the vacuole or mitochondria, and this could promote TORC1 activation independently of Gtr1/2. It has in fact been reported that the vacuole-associated Pib2 protein containing a FYVE domain acts in parallel with Gtr1 to promote TORC1 activation ([@bib38]; [@bib74]). Furthermore, in an in vitro TORC1 kinase assay using isolated vacuoles, the addition of glutamine was found to stimulate TORC1 activity in a manner dependent on Pib2 but not Gtr1 ([@bib71]). We thus also analyzed the role of Pib2 and found that HA-Npr1 is normally hyperphosphorylated after FCCP addition to *pib2∆* mutant cells ([Figure 5G](#fig5){ref-type="fig"}).

In conclusion, the above experiments indicate that H^+^ influx mediated even by a protonophore elicits a cellular response resulting in Rag/Gtr-dependent, Pib2-independent, TORC1 activation. They further suggest that if the cytosol becomes too acidic, an additional control likely impedes Sch9 phosphorylation by activated TORC1.

Inhibition of the vacuolar V-ATPase activates TORC1 {#s2-6}
---------------------------------------------------

We observed that addition of amino acids, cytosine, or NH~4~^+^ to growing cells does not detectably change their cytosolic pH (data not shown). This was expected, given the high buffering capacity of the cytosol and the compensating H^+^ efflux activity of the Pma1 H^+^-ATPase, which is stimulated under acidic conditions as long as glucose is present ([@bib16]; [@bib72]). We then examined whether an increase of cytosolic H^+^, imposed without changing the composition of the external medium, might also lead to TORC1 activation. An H^+^ increase can in principle be caused by inhibition of the vacuolar V-ATPase, as this enzymatic complex catalyzes ATP-dependent uptake of H^+^ into the vacuole in order to acidify the organelle, to compensate for the constant H^+^ efflux mediated by H^+^-coupled vacuolar transporters, and to control the cytosolic pH ([@bib37]). We thus tested the effects of two inhibitors of the V-ATPase, concanamycin A (CMA) and bafilomycin A (BAF) ([Figure 6](#fig6){ref-type="fig"}). Addition of CMA to proline-grown cells did not significantly change the cytosolic pH of the cells ([Figure 6A](#fig6){ref-type="fig"}). This suggests that Pma1-dependent efflux and the buffering capacity of the cytosol prevented the expected increase in cytosolic H^+^. BAF addition did cause a slight but significant drop in the cytosolic pH, suggesting that this treatment caused stronger inhibition of the V-ATPase ([Figure 6E](#fig6){ref-type="fig"}). Remarkably, both CMA and BAF treatment resulted in stimulation of TORC1 activity, as judged by Rap-sensitive hyperphosphorylation of Npr1 ([Figure 6B](#fig6){ref-type="fig"} and [Figure 6F](#fig6){ref-type="fig"}, respectively) and by a transient increase in Sch9 phosphorylation ([Figure 6C](#fig6){ref-type="fig"} and [Figure 6G](#fig6){ref-type="fig"}, respectively). No increase in Npr1 phosphorylation was detected in either CMA- or BAF-treated *gtr1∆ gtr2∆* mutant cells ([Figure 6D and H](#fig6){ref-type="fig"}, respectively). We conclude that inhibition of the V-ATPase is associated with efficient Rag/Gtr-dependent stimulation of TORC1 activity, even when this inhibition is not sufficient to cause a detectable lowering of the cytosolic pH.

![Inhibition of the vacuolar V-ATPase activates TORC1.\
(**A**) w-t cells expressing pHluorin (strain ES075) were grown on Gluc Pro medium. The cytosolic pH was monitored for 30 min at regular intervals. Concanamycin A (CMA) (1 µM) or its solvent (0.2% EtOH) was added at 1 min. (**B**) Left. w-t cells expressing HA-Npr1 from a plasmid were grown on Gluc Pro medium. Cells were collected before and at various times after addition of CMA (1 µM) or its solvent (0.2% EtOH). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. Right. Same except that half of the culture was treated with Rap for 30 min before CMA addition. (**C**) Same as in B except that crude extracts from w-t cells were immunoblotted with anti-(P) T^737^-Sch9 and anti-Sch9~Total~ antibodies. (**D**) Same as in B except that w-t and *gtr1Δ gtr2Δ* cells were analyzed. (**E, F, G, H**) Same as in A, B, C and D, respectively, except that cells were treated with bafilomycin A (BAF) (1 µM). The data of [Figure 6A and E](#fig6){ref-type="fig"} and those of [Figure 5A](#fig5){ref-type="fig"} were obtained in the same experiments but are presented in separate graphs for clarity.](elife-31981-fig6){#fig6}

TORC1 activation in response to increased cytosolic H^+^ requires the Pma1 H^+^-ATPase {#s2-7}
--------------------------------------------------------------------------------------

Activation of TORC1 in the above-described situations (H^+^ influx, increased in cytosolic H^+^) might involve an uncharacterized sensor of intracellular H^+^, capable of transmitting this signal to TORC1. Alternatively, the Pma1 H^+^-ATPase might control TORC1 activity upon sensing H^+^ influx or increase in cytosol. For instance, Pma1 activity increases under acidic conditions, and this coincides with a reduction of its Km for ATP, possibly via allosteric control ([@bib16]; [@bib72]). We hypothesized that the particular state adopted by the H^+^-ATPase in response to increased H^+^ might stimulate certain factors controlling TORC1 activity. To test this possibility, we thought of expressing in yeast, instead of the endogenous Pma1, a heterologous H^+^-ATPase known to be catalytically active in yeast. We reasoned that if TORC1 activation depends on a signaling capability of Pma1, an H^+^-ATPase from a distant species should fail to activate TORC1 in response to an increase in cytosolic H^+^.

According to previous reports, several plant H^+^-ATPases are active when expressed in yeast strains where the essential *PMA1* gene and its non-essential paralog *PMA2* (expressed to a much lower level) are deleted or repressed ([@bib48]; [@bib53]). The wild-type forms of these plant H^+^-ATPases typically compensate only partially for the lack of Pma1. It is possible, however, to isolate mutant derivatives sustaining faster growth, particularly on low-pH media where cells need high H^+^-ATPase activity to maintain a neutral cytosolic pH ([@bib48]). For instance, the H^+^-ATPase Pma4 of tobacco (*Nicotiana plumbaginifolia*) restores limited growth to a *pma1∆ pma2∆* double*-*null mutant. A truncated Pma4 protein called Pma4^882ochre^, lacking the last 71 C-terminal amino acids as a result of an ochre nonsense mutation in codon 882 of the *PMA4* gene, is able to support faster growth of yeast *pma1∆ pma2∆* cells ([@bib43]). We thus studied TORC1 activation in cells expressing either the endogenous *PMA1* gene or the tobacco plant *PMA4^822ochre^* gene. As most the above experiments were carried out with strains having the ∑1278b background, we first isolated a *GAL1-PMA1 pma2∆* derivative of this strain, where the *PMA1* gene is placed under the control of the galactose-inducible, glucose-repressible *GAL1* promoter. This strain can grow on galactose but not glucose, unless it contains a plasmid expressing the endogenous *PMA1* gene or the tobacco *PMA4^822ochre^* gene under the control of the *PMA1* promoter ([Figure 7A](#fig7){ref-type="fig"}). We cultured *GAL-PMA1 pma2∆* cells expressing *PMA1* or *PMA4^822ochre^* on glucose proline medium, as in the above-described experiments. We found cells expressing *PMA4^822ochre^* to grow more slowly ([Figure 7B](#fig7){ref-type="fig"}). This shows that the mutant plant H^+^-ATPase does not fully compensate for the lack of Pma1. Accordingly, compared to the cytosolic pH of *PMA1*-expressing cells, that of *PMA4^822ochre^*-expressing cells was slightly lower ([Figure 7C](#fig7){ref-type="fig"}). H^+^-coupled uptake of β-ala (1 mM) was also significantly lower in the latter cells (data not shown). We therefore lowered the concentration of β-ala provided to *PMA1*-expressing cells in order to reach an uptake rate equivalent to that measured in *PMA4^822ochre^*-expressing cells ([Figure 7D and F](#fig7){ref-type="fig"}). As expected, and whichever gene was expressed, \[^14^C\]-β-ala uptake was inhibited after a brief treatment of the cells with FCCP. This shows that in both cases, β-ala uptake is coupled to H^+^ influx ([Figure 7D and F](#fig7){ref-type="fig"}). Upon transfer of the cells to a glucose-free medium, uptake of β-ala into *PMA1*-expressing cells was also strongly reduced ([Figure 7D and F](#fig7){ref-type="fig"}). This was expected, since Pma1 is inhibited under these conditions. This reduction was much less pronounced in *PMA4^822ochre^*-expressing cells ([Figure 7D and F](#fig7){ref-type="fig"}). This result can be readily explained by the fact that inactivation of H^+^-ATPases upon glucose starvation, a regulation conserved between yeast and plant H^+^-ATPases, requires a C-terminal auto-inhibitory region which the truncated protein Pma4^822ochre^ lacks ([@bib48]; [@bib58]). Next, under conditions of equal H^+^-coupled β-ala uptake into *PMA1*- and *PMA4^822ochre^*-expressing cells, we analyzed TORC1 activity. Phosphorylation of Npr1 was found to increase moderately upon addition of β-ala at low concentration (0.1 mM) to *PMA1*-expressing cells, but this variation was significant, as judged by its sensitivity to Rap ([Figure 7E](#fig7){ref-type="fig"}). Remarkably, no increase in Npr1 phosphorylation was detected in *PMA4^822ochre^*-expressing cells ([Figure 7E](#fig7){ref-type="fig"}). Furthermore, basal phosphorylation of Npr1 in these cells did not increase, despite the lower pH of their cytosol ([Figure 7E and C](#fig7){ref-type="fig"}). Non-activation of TORC1 in *PMA4^822ochre^*-expressing cells was even clearer when Sch9 phosphorylation was used as readout ([Figure 7G](#fig7){ref-type="fig"}). Basal phosphorylation of Sch9 before β-ala addition was also reduced in *PMA4^822ochre^*-expressing cells ([Figure 7G](#fig7){ref-type="fig"}). Non-activation of TORC1 in *PMA4^822ochre^*-expressing cells upon β-ala uptake was also observed in the background of another strain deleted of both *PMA1* and *PMA2* ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). We next analyzed TORC1 activation after addition of glutamine, leucine, or arginine, each activation being deficient in the *gtr1Δ gtr2Δ* strain ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). As with β-ala, the external concentration of each amino acid was first adjusted to reach equivalent uptake in *PMA1*- and *PMA4^822ochre^*-expressing cells. Using these conditions, we observed a Rap-sensitive activation of TORC1 in the cells expressing *PMA1* but not in those expressing *PMA4^822ochre^* ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). We also analyzed TORC1 activation upon FCCP addition. In both *PMA1*- and *PMA4^822ochre^*-expressing cells, as expected, the ionophore caused a rapid drop in the cytosolic pH, to a value close to the pH of the buffered external medium ([Figure 7C](#fig7){ref-type="fig"}). Also as expected, this induced strong hyperphosphorylation of Npr1 in control *PMA1*-expressing cells ([Figure 7H](#fig7){ref-type="fig"}). In contrast, FCCP addition did not increase Npr1 phosphorylation in *PMA4^822ochre^*-expressing cells ([Figure 7H](#fig7){ref-type="fig"}). Similar results were obtained after treatment with BAF: Npr1 phosphorylation was found to increase in *PMA1*-expressing but not in *PMA4^822ochre^*-expressing cells ([Figure 7I](#fig7){ref-type="fig"}). These results show that the endogenous Pma1 H^+^-ATPase plays an essential role in Rag/Gtr-dependent TORC1 activation in response to increased cytosolic H^+^. The importance of Pma1 in stimulating TORC1 activity was also illustrated by the ability of *PMA1*-expressing cells to resume growth following exposure to Rap, whereas *PMA4^822ochre^-*expressing cells failed to do so ([Figure 7J](#fig7){ref-type="fig"}).

![TORC1 activation in response to increased cytosolic H^+^involves the Pma1 H^+^-ATPase.\
(**A**) *GAL1p-PMA1 pma2Δ* cells transformed with the YCp(Sc)PMA1, YEp(Np)PMA4^882Ochre^, or pFL36 (empty) plasmid (-) were grown for 3 days on solid medium with Pro as sole N source and Gal or Gluc as carbon source. (**B**) *GAL1p-PMA1 pma2Δ* cells expressing (Sc)Pma1 or (Np)Pma4^882Ochre^ from a plasmid (as in A) were grown on Gluc Pro medium in a microplate reader for 40 hr. Data points represent averages of the OD at 660 nm of two biological replicates; error bars represent SD. (**C**) Strains and growth conditions as in B, except that the strains were also transformed with a plasmid (pHl-U) expressing *pHluorin*. The cytosolic pH was monitored during growth with or without addition, starting at 1 min, of FCCP (20 µM) for various times. (**D**) Left. Cells as in B but also expressing HA-Npr1 from a plasmid were grown on Gluc NH~4~^+^ medium. After a shift to Gluc Pro medium for 3 hr, \[^14^C\]-β-ala (0.1 or 1 mM) was added to the medium before measuring the incorporated radioactivity at various times. Right. Strains and growth conditions as in left. Uptake via Gap1 of \[^14^C\]-β-ala (provided at 0.1 mM to (*Sc*)*PMA1*-expressing cells and at 1 mM to *(Np)PMA4^882Ochre^*-expressing cells) was measured before and after glucose starvation for 5 min or after addition of FCCP (20 µM) or its solvent alone (0.2% EtOH) for 5 min. Plotted values represent percentages of initial Gap1 activity, and correspond to means ± SD of two independent experiments. (**E**) Top. Strains and growth conditions as in D, except that the cells were collected before and 4 and 10 min after addition of β-ala (0.1 or 1 mM). Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies. Bottom. Same as in top panel, except that only (*Sc*)*PMA1*-expressing cells were collected and half of the culture was treated for 30 min with Rap. (**F**) Experiments similar to those in D, except that the cells harbored an empty *URA3* plasmid instead of the HA-Npr1 plasmid and were grown on Gluc Pro medium. (**G**) Top. Strains and growth conditions were as in F, and cells were treated as in E. Crude extracts were prepared and immunoblotted with anti-(**P**) T^737^-Sch9 and anti-Sch9~Total~ antibodies. Bottom. Same as in top panel except that (*Sc*)*PMA1*-expressing cells were collected and half of the culture was treated for 30 min with Rap. (**H--I**) Strains, growth conditions, and immuno-detection as in E except that cells were collected before and at various times after addition of FCCP (20 µM) or BAF (1 µM). (**J**) Rapamycin recovery assay for *GAL1p-PMA1 pma2Δ* cells expressing (Sc)Pma1 or (Np)Pma4^882Ochre^ from plasmids. Cells were treated or not with Rap (200 ng/ml) for 6 hr, washed twice, plotted in two-fold serial dilutions on solid Gluc Pro medium, and incubated for 4 days. (**K**) w-t and *gtr1Δ gtr2Δ* cells expressing HA-Npr1 from a plasmid and *GAL1p-PMA1 pma2Δ* cells co-expressing (Sc)Pma1 or (Np)Pma4^882Ochre^ and HA-Npr1 from plasmids were grown on Gluc NH~4~^+^ medium. After a shift to Gluc Pro medium for 3 hr, cells were collected before and 30 min after addition of NH~4~^+^ (5 mM). Cells were also collected after addition of Rap for 30 min, followed by addition of NH~4~^+^ (5 mM) for 30 min. Crude extracts were prepared and immunoblotted with anti-HA and anti-Pgk antibodies.](elife-31981-fig7){#fig7}

It has been reported that the Rag GTPases are not required for sustained activation of TORC1 in the presence of NH~4~^+^ ([@bib69]). In support of this view, NH~4~^+^ addition to proline-grown cells caused Rap-sensitive hyperphosphorylation of Npr1 in both wild-type and *gtr1∆ gtr2∆* mutant cells ([Figure 7K](#fig7){ref-type="fig"}). Furthermore, sustained TORC1 activation after NH~4~^+^ addition is reported to depend on the enzymes converting NH~4~^+^ to glutamate ([@bib17]; [@bib46]), the main N donor in amino acid biogenesis reactions. Interestingly, upon NH~4~^+^ addition to proline-grown cells, we found TORC1 to be properly activated by NH~4~^+^ regardless of the H^+^-ATPase produced (Pma1 or the plant Pma4^822ochre^) ([Figure 7K](#fig7){ref-type="fig"}). This result shows that TORC1 can be properly activated in *PMA4^822ochre^*-expressing cells. It also suggests that Pma1 is required for TORC1 activation in response to H^+^ influx but not to an increase in internal amino acids.

Discussion {#s3}
==========

Uptake of amino acids into N-deprived yeast cells causes Rag/Gtr-dependent activation of TORC1. The actual signal and the underlying mechanism of this cellular response remain unknown. Our study shows that what triggers this activation is the H^+^ influx coupled to transport by H^+^/amino-acid symporters. A similar response is observed upon H^+^-dependent uptake of cytosine, or even fructose, but not when an equivalent amount of fructose enters the cells via passive transport systems. The activation of TORC1 can even be elicited by diffusion of extracellular H^+^ via a protonophore or by inactivation of the vacuolar V-ATPase (which also causes an increase in cytosolic H^+^). We further show that TORC1 activation in response to an H^+^ influx and/or an increase in cytosolic H^+^ requires the Rag GTPases encoded by the *GTR* genes. It does not, however, require the Pib2 protein recently shown to act in parallel with the Rag/Gtr proteins to activate TORC1. Finally, we show that the Pma1 H^+^-ATPase plays a central role in this TORC1 activation pathway.

Yeast cells typically adapt to starvation for any nutrient by reducing TORC1 activity. This is probably because mechanisms capable of sensing the nutritional status of the cell impede the activation of TORC1, and not just because of a possible drop in H^+^-coupled uptake of this nutrient. This reduction of TORC1 activity typically coincides with increased synthesis of large amounts of high-affinity H^+^-symporters able to assimilate replenishing compounds, for example, Gap1 for amino acids, Pho84 for phosphate, Sul1 and Sul2 for sulfate, Zrt1 for zinc, Fcy2 for cytosine, and Fur4 for uracil. Furthermore, many permeases for the non-limiting nutrients likely undergo parallel increased endocytosis and degradation, as such responses have been observed in rapamycin-treated cells ([@bib6]). This permease reconfiguration at the plasma membrane probably causes an overall reduction of the H^+^ influx. Our results suggest that the H^+^-symporters that are derepressed under starvation conditions are potentially able to reactivate TORC1 once their substrate becomes available again in the medium. In other words, H^+^ influx via these transporters could provide a general signal for reactivating TORC1 upon relief from diverse starvation conditions. On the other hand, sustained activation of TORC1 probably requires efficient assimilation of the internalized nutrient. Accordingly, longer term TORC1 activation after addition of a preferential N source such as NH~4~^+^ is reported to require glutamine accumulation and/or synthesis ([@bib69]). The influx of H^+^ coupled to uptake of any growth-limiting nutrient might thus provide a general signal for rapid, transient TORC1 reactivation in order to prepare cells for subsequent growth acceleration or restart once the nutrient has been properly assimilated. It could also contribute to the reactivation of TORC1 observed upon addition of glucose to glucose-starved cells, as although glucose enters cells via Hxt facilitators it also reactivates Pma1, which in turn drives the H^+^-coupled uptake of amino acids and other nutrients.

Uptake of amino acids by N-starved cells is also reported to elicit transient activation of PKA, resulting in stimulation of trehalase by phosphorylation ([@bib12]). According to current models, PKA could be activated via a signaling pathway stimulated by Gap1 acting as a transceptor, and a similar function has been described for other H^+^-coupled nutrient transporters found to be derepressed under particular starvation conditions ([@bib66]). Yet, the mechanisms underlying this signaling remain unknown. It is tempting to envisage an alternative model according to which the signal eliciting PKA activation is the H^+^ influx coupled to the nutrient uptake reaction, as in the case of TORC1. This model is worth considering, since addition of FCCP to N-starved cells results in stimulation of trehalase activity ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

In a previous study, addition of excess Gln to proline-grown cells was found to cause a rapid, transient activation of TORC1, not observed in the *gtr1∆* mutant, followed by a more sustained TORC1 activity, still observed in *gtr1∆* cells ([@bib69]). This Gtr1-independent TORC1 activation is reminiscent of the situation described in mouse cells, where Gln activates mTORC1 in a manner independent of RagA and RagB ([@bib36]). Similarly, direct addition of Gln to isolated vacuoles elicits TORC1 activation in vitro in a Gtr1-independent manner ([@bib71]). In contrast, this response requires the Pib2 protein proposed to act in parallel with Gtr1 to activate TORC1 ([@bib38]; [@bib74]). These observations suggest that Gln uptake first elicits a transient, Gtr1-dependent activation of TORC1, and we propose that the signal of this early activation is the H^+^ influx coupled to Gln transport. The subsequent sustained activation of TORC1, in contrast, is suggested to be promoted by the intracellular accumulation of Gln ([@bib69]). The actual function of Pib2 in this process needs further investigation. The same applies to Gtr1/2 because, while sustained TORC1 activation occurs normally after Gln addition to *gtr1∆* cells ([@bib69]), we failed to observe it in the double *gtr1∆ gtr2∆* mutant, in keeping with another study ([@bib74]).

We have found the Sch9 kinase to be stimulated by TORC1 in response to an increase in cytosolic H^+^. This observation is interesting, in the light of the recent finding that Sch9 contributes to pH homeostasis by controlling the assembly and activity of the vacuolar V-ATPase ([@bib77]). This is relevant because the latter, together with the plasma membrane H^+^-ATPase, contributes importantly to controlling the cytosolic pH ([@bib37]). Yet according to other reports, Sch9 phosphorylation and cell growth are reduced when the cytosol becomes acidic (e.g. after a drop to a pH near 6), for instance under glucose starvation or when Pma1 synthesis is reduced ([@bib11]; [@bib52]; [@bib72]). It thus seems that even though Sch9 is activated by an H^+^ influx and/or by an increase in cytosolic H^+^, it is inhibited when the cytosol becomes too acidic, and this causes growth inhibition. In FCCP-treated cells, accordingly, TORC1 appears to be efficiently activated (as judged by hyperphosphorylation of the Npr1 kinase), but this is not accompanied by Sch9 phosphorylation. This suggests that a particular mechanism sensitive to acidic conditions hampers Sch9 phosphorylation by activated TORC1. Such a control seems physiologically relevant, as acidification of the cytosol is stressful for the cell and stimulation of growth under these conditions would be inappropriate. Accordingly, other stresses are reported to promote dephosphorylation of Sch9 without affecting the TORC1-regulated Tap42-PP2A branch controlling Npr1 phosphorylation ([@bib33]).

A key question raised by our work is: what is the molecular mechanism responsible for stimulation of TORC1 activity in response to H^+^ influx and/or an increase in cytosolic H^+^? Our data indicate that the plasma membrane Pma1 H^+^-ATPase plays a central role in this cellular response. Specifically, TORC1 activity fails to be stimulated in response to H^+^-coupled uptake of amino acids, ionophore-mediated H^+^ diffusion, or inhibition of the V-ATPase in cells producing the tobacco plant Pma4^822ochre^ instead of Pma1. Furthermore, these cells display a strongly reduced ability to restart growth after exposure to rapamycin. At least two models can be proposed to account for these observations. On the one hand, non-activation of TORC1 might result indirectly from the inability of Pma4^822ochre^ to fully compensate for the lack of Pma1 activity. We did find *PMA4^822ochre^* -expressing cells to grow more slowly and their cytosol to be slightly acidic. This might trigger adaptive feedback mechanisms impeding TORC1 reactivation. Yet in *PMA4^822ochre^*-expressing cells we found TORC1 to be properly activated after NH~4~^+^ addition, and this shows that TORC1 activity can be efficiently stimulated at least via the Rag/Gtr-independent pathway seemingly responding to internal amino acids ([@bib69]). Alternatively, the essential role of Pma1 in TORC1 activation in response to H^+^ influx might reflect the ability of Pma1 to stimulate a signaling pathway controlling TORC1 activity. For instance, the activity of Pma1 is known to increase when the concentration of H^+^ in the cytosol rises, and this control involves a decreased Km for ATP ([@bib16]; [@bib72]). This activity increase also likely occurs when protons are co-transported with nutrients via plasma membrane H^+^-symporters. This stimulation of Pma1 activity, possibly involving a conformational change of the H^+^-ATPase, might be transmitted to cytosolic factors that would in turn modulate TORC1 activity. A role of Pma1 in signaling to TORC1 is attractive, because Pma1 is the main ATP-consuming enzyme of yeast and is thus ideally positioned for sensing cellular ATP levels. Furthermore, as mentioned above, Pma1 stimulation by H^+^ influx could also give cells a general mechanism for sensing relief from starvation for any nutrient and for reactivating TORC1 in response to this relief. Other observations support a role of Pma1 in signaling to TORC1. For instance, TORC1 inhibition has been observed when Pma1 synthesis is reduced ([@bib11]). Furthermore, yeast TORC1 is rapidly inhibited under glucose starvation ([@bib73]), this coinciding with polymerization of the kinase complex into a single, vacuole-associated cylindrical structure ([@bib60]). Although a specific mechanism involving phosphorylation of the Kog1 subunit is reported to contribute to this TORC1 inhibition ([@bib34]), a role of Pma1 might also be considered, as this H^+^-ATPase is subject to rapid and reversible auto-inhibition under these conditions ([@bib57]; [@bib67]). Interestingly, TORC1 has been reported recently to be required for full activity of Pma1 ([@bib45]), suggesting the existence of some crosstalk between Pma1 and TORC1. The model according to which Pma1 is capable of controlling TORC1 via signaling also seems reasonable in the light of previous works showing that the Na^+^/K^+^-ATPase of animals cells, a P-type ATPase structurally similar to Pma1 and other H^+^-ATPases, is engaged in dynamic interactions with other proteins, including the Src tyrosine kinase. The interaction with Src is modulated by the conformation of the ion pump and initiates signal transduction processes ([@bib8]). As the cytosolic region of the Na^+^/K^+^-ATPase interacting directly with Src ([@bib40]) is relatively well conserved in the yeast H^+^-ATPase, we introduced several substitutions into this region of Pma1 with a view of disrupting possible interactions with other factors. The generated Pma1 variants, however, behaved normally in TORC1 activation assays.

In conclusion, our results show that cytosolic H^+^ and Pma1 are major actors in TORC1 activation in response to active nutrient uptake. They also raise the interesting possibility that Pma1 might control TORC1 via signaling. Further work is needed to evaluate this model, which would open important prospects for work on nutritional signaling in yeast and other organisms.

Materials and methods {#s4}
=====================

  Reagent type (species) or resource   Designation                                                   Source or reference                          Identifiers                                                                  Additional information
  ------------------------------------ ------------------------------------------------------------- -------------------------------------------- ---------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------
  Antibody                             anti-GFP (mouse monoclonal)                                   Roche (Belgium)                              11814460001 ; RRID : [AB_390913](https://scicrunch.org/resolver/AB_390913)   (1:10000)
  Antibody                             anti-Pma1 (rabbit polyclonal)                                 ([@bib9])                                    RRID : [AB_2722567](https://scicrunch.org/resolver/AB_2722567)               (1:5000)
  Antibody                             anti-HA (12CA5) (mouse monoclonal)                            Roche (Belgium)                              11583816001 ; RRID : [AB_514506](https://scicrunch.org/resolver/AB_514506)   (1:5000)
  Antibody                             anti-Pgk (mouse monoclonal)                                   Invitrogen/Life technologies (Belgium)       459250 ; RRID : [AB_221541](https://scicrunch.org/resolver/AB_221541)        (1:10000)
  Antibody                             anti-(P)T737-Sch9 (rabbit purified polyclonal antibody)       This paper                                   RRID : [AB_2722566](https://scicrunch.org/resolver/AB_2722566)               GeneCust compagny; rabbit purified polyclonal antibody; against CKFAGF(pT)FVDESAIDE; (1:2500)
  Antibody                             anti-Sch9Total (rabbit polyclonal)                            ([@bib60])                                                                                                                (1:20000)
  Antibody                             anti-mouse IgG (whole Ab), HRP conjugate (polyclonal)         GE Healthcare/Fisher Scientific (Belgium)    NA931 ; RRID : [AB_772210](https://scicrunch.org/resolver/AB_772210)         (1:10000)
  Antibody                             anti-rabbit IgG (whole Ab), HRP conjugate (polyclonal)        GE Healthcare/Fisher Scientific (Belgium)    NA934 ; RRID : [AB_772206](https://scicrunch.org/resolver/AB_772206)         (1:10000)
  Commercial assay or kit              Glucose Assay Kit                                             Sigma-Aldrich (Germany)                      GAGO20                                                                       Manufacture instructions
  Chemical compound, drug              R-5000 Rapamycin                                              LC Laboratories (U.S.A.)                     53123-88-9                                                                   200 ng/ml
  Chemical compound, drug              CellTracker Blue CMAC Dye                                     Life technologies (Belgium)                  C2110                                                                        
  Chemical compound, drug              Lumi-LightPlus Western blotting substrate                     Roche (Belgium)                              12015196001                                                                  Manufacture instructions
  Chemical compound, drug              Digitonin                                                     Sigma-Aldrich (Germany)                      D141                                                                         
  Chemical compound, drug              Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP)   Sigma-Aldrich (Germany)                      C2920                                                                        20 µM
  Chemical compound, drug              Concanamycin A (Folimycin)                                    Abcam (U.K.)                                 ab144227                                                                     1 µM
  Chemical compound, drug              Bafilomycin A1                                                Cell Signaling Technology (France)           54645S                                                                       1 µM
  Chemical compound, drug              Alanine, β-\[1--14C\]                                         Hartmann analytic (Germany)                  ARC0183                                                                      
  Chemical compound, drug              Arginine, L-\[14C(U)\]                                        Perkin-Elmer (Belgium)                       NEC267E2                                                                     
  Chemical compound, drug              Leucine, L-\[14C(U)\]                                         Perkin-Elmer (Belgium)                       NEC279E0                                                                     
  Chemical compound, drug              Glutamine, L-\[14C(U)\]                                       Perkin-Elmer (Belgium)                       NEC4510                                                                      
  Chemical compound, drug              Fructose, D-\[14C(U)\]                                        Hartmann analytic (Germany)                  ARC0116                                                                      
  Software, algorithm                  GraphPad Prism 5                                                                                           RRID:[SCR_015807](https://scicrunch.org/resolver/SCR_015807)                 Statistical analysis and graphs representation

Yeast strains, plasmids, and growth conditions {#s4-1}
----------------------------------------------

The yeast strains used in this study ([Table 1](#table1){ref-type="table"}) derive from the Σ1278b wild type, the only exceptions being YPS14-4 (W303), JW00035 (W303), CEN.PK2-1c (VW1A), EBY.VW 4000, and I3. Cells were grown at 29°C on a minimal medium buffered at pH 6.1 ([@bib35]), with glucose (Gluc) (3% w/v), maltose (3% w/v), galactose (Gal) (3% w/v), or ethanol (EtOH) (1% v/v) as a carbon source. For cultures in Gal medium, a low concentration of Gluc (0.3% w/v) was also added to boost initiation of growth. The nitrogen (N) sources added to liquid growth media were NH~4~^+^ as (NH~4~)~2~SO~4~ (20 mM), proline (Pro) (10 mM), or urea (10 mM). For strain YPS14-4 and its derivative expressing *PMA4^882-ochre^*, cells were grown on the same buffered minimal medium adjusted to pH 6.5 to improve growth. In all experiments, cells were examined or collected during exponential growth, a significant and regular number of generations after seeding. Our experience is that these precautions and the use of a minimal medium that is buffered considerably improve the reproducibility of data between biological replicates ([@bib75]). When indicated, rapamycin (Rap) at 200 ng/ml concentration was added for 30 min. The *ura3* mutation present in all strains was complemented by transformation with a plasmid, for example, pFL38. Comparative analyses of growth were performed by growing cells in a Greiner 24-well microplate incubator coupled to a SYNERGY multi-mode reader (BioTek Instruments). The plasmids used in this study are listed in [Table 2](#table2){ref-type="table"}.
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###### Yeast strains used in this study

  Strain            Genotype                                                                                                                       Reference or source
  ----------------- ------------------------------------------------------------------------------------------------------------------------------ -----------------------
  23344 c           *ura3*                                                                                                                         Laboratory collection
  EK008             *gap1Δ ura3*                                                                                                                   Lab collection
  ES032             *can1Δ ura3*                                                                                                                   ([@bib26])
  ES029             *gap1Δ can1Δ ura3*                                                                                                             ([@bib26])
  MA032             *gap1Δ BUL2-HA ura3*                                                                                                           ([@bib46])
  27038a            *npi1-1^rsp5^ ura3*                                                                                                            ([@bib31])
  OS27-1            *bul1Δ bul2Δ ura3*                                                                                                             Lab collection
  34210 c           *gap1Δ put4Δ ura3*                                                                                                             Lab collection
  33007 c           *gap1Δ ura3 leu2*                                                                                                              Lab collection
  30911b            *car1 ura3*                                                                                                                    Lab collection
  CG059             *gap1Δ can1Δ ura3 leu2*                                                                                                        ([@bib26])
  OS26-1            *gtr1Δ gtr2Δ ura3*                                                                                                             Lab collection
  CEN.PK2-1c        *leu2-3,112 ura3-52 trp1-289 his3-Δ1 MAL2-8c SUC2 hxt17Δ*                                                                      ([@bib76])
  EBY.VW4000        *hxt1-17Δ gal2Δ stl1Δ agt1Δ mph2Δ mph3Δ leu2-3,112 ura3-52 trp1-289 his3-Δ1 MAL2-8c SUC2*                                      ([@bib76])
  I3                *EBY.VW4000 URA3::FSY1*                                                                                                        ([@bib61])
  CG146             *seh1Δ ura3*                                                                                                                   This study
  CG148             *pib2Δ ura3*                                                                                                                   This study
  CG150             *iml1Δ ura3*                                                                                                                   This study
  35652d            *fcy1 ura3*                                                                                                                    This study
  ES075             *uga1::loxP-kanMX-loxP-GPD1p-pHluorin ura3*                                                                                    This study
  YPS14-4           *ade 2--101, leu2Δ1, his3-Δ200, ura3--52, trp1Δ63, lys2--801 pma1Δ::HIS3, pma2Δ::TRP1 + YCp-*(*Sc*)*PMA1 (LEU2)*               ([@bib70])
  PMA4--882Oc hre   *ade 2--101, leu2Δ1, his3-Δ200, ura3--52, trp1Δ63, lys2--801 pma1Δ::HIS3, pma2Δ::TRP1 + YEp-PMA1p-(Np)PMA4^882ochre^ (LEU2)*   ([@bib43])
  JW00035           *leu2-3-112 ura3-1 trp1-1 his3-11-15 ade2-1 can1-100 sch9Δ::TRP1*                                                              ([@bib77])
  JX023             *GAL1p-PMA1 pma2Δ ura3 leu2*                                                                                                   This study
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###### Plasmids used in this study

  Plasmid         Description                                 Reference or source
  --------------- ------------------------------------------- ----------------------
  pFL38           CEN-ARS (URA3)                              ([@bib5])
  pFL36           CEN-ARS (LEU2)                              ([@bib5])
  p416 GAL1       CEN-ARS GAL1p (URA3)                        ([@bib49])
  pJOD10          p416 GAL1p-GAP1-GFP (URA3)                  ([@bib50])
  pCJ038          p416 GAL1p -GAP1(K9R,K16R)-GFP (URA3)       ([@bib41])
  pMA065          p416 GAL1p -GAP1-126-GFP (URA3)             ([@bib47])
  pMA091          p416 GAL1p -GAP1-126-K9R,K16R-GFP (URA3)    ([@bib47])
  pCH500          CEN-ARS-GAP1 (URA3)                         ([@bib30])
  pHcGAP1         YEp-HcGAP1 (URA3)                           ([@bib78])
  pES103          YEp-HA-NPR1 (LEU2)                          This study
  pAS103          YEp-HA-NPR1 (URA3)                          ([@bib65])
  pCJ315          CEN-ARS (LEU2-HIS3-LYS2)                    Lab collection
  pMYC008         YCp-AGP1p-LACZ (HIS3 TRP1 LEU2)             Lab collection
  pES154          YCp-AGP1p-LACZ (HIS3 TRP1)                  This study
  pHl-U           YEp-ADH1p-pHluorin (URA3)                   ([@bib51]; [@bib81])
  pHl-I           YCp-loxP-kanMX-loxP-GPD1p-pHluorin (URA3)   ([@bib51]; [@bib81])
  pCJ366          YEp (TRP1-LEU2-HIS3)                        Lab collection
  pPS15-P1        YCp-(Sc)PMA1 (LEU2)                         ([@bib70])
  pPMA4882ochre   YEp-PMA1p-(Np)PMA4^882ochre^ (LEU2)         ([@bib43])

Fluorescence microscopy {#s4-2}
-----------------------

Growing cells were laid on a thin layer of 1% agarose and viewed at room temperature with a fluorescence microscope (Eclipse E600; Nikon) equipped with a 100 differential interference contrast, numerical aperture (NA) 1.40 Plan-Apochromat objective (Nikon) and appropriate fluorescence light filter sets. Images were captured with a digital camera (DXM1200; Nikon) and ACT-1 acquisition software (Nikon) and processed with Photoshop CS (Adobe Systems). In each figure, we typically show only a few cells, representative of the whole population. Labeling of the vacuolar membrane with CMAC fluorescent dye was performed by adding 1 µl of the dye to 5 ml of culture at least 30 min prior to visualization.

Protein extracts and western blotting {#s4-3}
-------------------------------------

For western blot analysis, crude cell extracts were prepared as previously described ([@bib31]). Proteins were transferred to a nitrocellulose membrane (Schleicher and Schuell; catalog number NBA085B) and probed with mouse anti-GFP (Roche; catalog number 11 814 460 001), anti-hemagglutinin (anti-HA) (12CA5; Roche), or anti-yeast 3-phosphoglycerate kinase (anti-PGK) (Invitrogen) or with rabbit anti-Pma1 ([@bib9]), anti-phospho-Thr^737^-Sch9, or anti-Sch9~Total~ (see below). Primary antibodies were detected with horseradish-peroxidase-conjugated anti-mouse or anti-rabbit immunoglobulin G secondary antibodies (GE Healthcare), followed by enhanced chemiluminescence (Roche; catalog number 12 015 196 001). Each Western blot was carried two to four times, a representative experiment is presented.

Generation and validation of the anti-phospho-Thr737-Sch9 antibody {#s4-4}
------------------------------------------------------------------

The antibody was produced by and purchased from the GeneCust company. The CKFAGF(pT)FVDESAID peptide containing phosphorylated Thr737 was injected into rabbit. The affinity of the antibody preparation was tested in an ELISA for the phosphorylated peptide. Antibody specificity was tested by western blot analysis of cell extracts isolated from proline-grown wild-type (w-t) and *sch9∆* strains, before and after addition of NH~4~^+^, well known to stimulate Sch9 phosphorylation ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The anti-Sch9~Total~ antibody was a kind gift of Robbie Loewith.

Measurements of cytosolic pH {#s4-5}
----------------------------

Yeast strains expressing a single *pHluorin* gene integrated into the genome or containing a multicopy plasmid expressing the *pHluorin* gene were grown at 29°C on Gluc proline buffered medium, pH 6.1, to OD660 \~0.2. Fluorescence intensities were recorded with a SYNERGY multi-mode microplate reader (BioTek Instruments) with emission filter 512/9 nm and excitation filters 395/9 and 475/9 nm, as previously reported ([@bib51]; [@bib81]). To eliminate the background fluorescence, pHluorin-nonproducing wild-type cells were grown in parallel, and the corresponding values at each excitation wavelength were subtracted from those of pHluorin-producing cells. The I395 nm to I475 nm emission intensity ratio was used to calculate the cytosolic pH. The fluorescence intensities of each strain were typically recorded in four separate cultures (1 ml culture per well) within one experiment (technical replicates), and the presented data are means ±SD of at least two independent experiments (biological replicates). The calibration curve was generated as described previously ([@bib51]; [@bib81]), with minor changes. The cell culture (100 ml, OD660 = 0.2) was filtered, washed, resuspended in 8 ml phosphate-buffered saline (Sigma) containing digitonin (175 μg/ml), and incubated for 15 min at RT. Digitonin was washed out and the cells were resuspended in 8 ml PBS (the OD of the cell suspension was about 2.5) and placed on ice. Then 40 µl aliquots were transferred to CELLSTAR black polystyrene clear-bottom 96-well microtiter plates (Greiner Bio-One) containing, per well, 160 μl citric acid/Na2HPO4 buffer at a pH ranging from 5.6 to 7.6 (in this volume, the OD was 0.5). Recording of pHluorin fluorescence emission and background subtraction were performed as described above. The I395 nm to I475 nm intensity ratio was calculated, plotted against the corresponding buffer pH, and fitted to a third-degree polynomial regression curve.

Uptake measurements of radiolabelled compounds {#s4-6}
----------------------------------------------

The accumulation of \[^14^C\]-labeled amino acids or \[^14^C\]-labeled-fructose was measured at the time points indicated as previously described ([@bib20]; [@bib27]). The radiolabeled compounds were purchased either from Perkin-Elmer or from Hartmann analytic. Data points represent averages of two biological replicates; error bars represent standard deviations (SD).

Measurement of total amino acid pools {#s4-7}
-------------------------------------

Yeast cultures (50 ml) were collected by centrifugation (7000 g for 3 min) and washed twice with 10 ml Milli-Q water. The final pellet was resuspended in 2 ml Milli-Q water and boiled for 15 min. To remove cell debris, suspensions were centrifuged at 13,000 *g* for 1 min and filtered (Millipore 0.45 μm). The resulting soluble fractions were subjected to amino acid analysis after AccQ Tag pre-column derivatization (Waters). For this an AccQ Tag Ultra UPLC column (Waters) with UV detection at 260 nm was used according to the manufacturer's recommendations ([@bib17]).

Assay of trehalase activity in N-deprived cells {#s4-8}
-----------------------------------------------

Cells growing on Gluc NH~4~^+^ medium were collected by filtration, and after washing and resuspension in Gluc medium without any N source, they were incubated overnight at 29°C with shaking. Cells were filtered, washed, and transferred again to fresh N-free Gluc medium for 30 min before addition of FCCP (20 μM). Culture samples were collected at various times and trehalase activity was measured in permeabilized cells as previously described ([@bib10]). Glucose levels were measured using the 'Glucose assay kit' (Sigma-Aldrich, Belgium).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"The yeast H^+^-ATPase Pma1 promotes Rag/Gtr-dependent TORC1 activation in response to H^+^-coupled nutrient uptake\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Guest Reviewing Editor and Jonathan Cooper as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers agree that the study is a well-designed set of technically sound experiments, with the exception of the quality of some Sch9 immunoblots (see comment 3). The manuscript provides an interesting and unusual explanation on how amino acid sufficiency is transmitted to TORC1 via Gtr1/2 in *S. cerevisiae*. We have decided to recommend the manuscript for publication in *eLife* after major revision. Specific comments are as follows.

1\) The main conclusion of this work, i. e., proton influx coupled to nutrient uptake stimulates TORC1, would be significantly strengthened if the authors performed an experiment expressing (preferably in a *gap1∆* background) either of two non-yeast solute transporters that pump the same solute but one as a proton symporter and the other through a different mechanism (sodium symporter, ATP-dependent transporter, etc.) and investigate whether only the proton symporter activates TORC1. Inspiration for such an experimental setup might be taken from Nicklin P, et al. Cell. 2009; 36(3):521-34.

2\) It is unclear which amino acids require Pma1 to activate TORC1 and which do not. This can be addressed experimentally. The authors should monitor TORC1 activity over time (with emphasis on the early time points) in ScPma1 and (Np)Pma4^822ochre^ expressing cells in response to different amino acids such as leucine (activates TORC1 via Gtr1/2) or glutamine (activates TORC1 also independently of Gtr1/2). They should ideally use *gtr1∆gtr2∆* cells as a control.

3\) Figures 1E, 5C, 5G, Figure 7---figure supplement 1B and Figure 1---figure supplement 2. Total Sch9 levels are not controlled properly. Figure 1---figure supplement 2 shows that the antiserum against dephosphorylated Sch9 is sensitive to phosphorylation. Sch9 immunoblots should be repeated with better reagents.

4\) The authors should determine whether Pib2 or SEACIT/SEACAT components are necessary for proton influx/Pma1 to activate TORC1. Gtr1/2 and Pib2 are believed to function independently, but the evidence does not rule out dependencies. Also, the SEACAT and SEACIT complexes regulate Gtr1/2 and TORC1. Single knockout mutants could be generated and analyzed.

5\) The role of Pma1 in TORC1 activation is intriguing. The use of a separation of function allele of Pma1 that loses the ability to signal to TORC1 would be a good complement to this work. Perhaps a screen for viable Pma1 alleles that present an EGO phenotype (i.e., fail to recover from rapamycin growth arrest) could yield such an allele. This would not be a make-or-break issue for publication but a suggestion to improve the manuscript.

6\) It is known that TORC1 is inactivated when cells are starved for a single amino acid such as leucine (in the case of *leu2∆* cells) or for phosphate, sulfate or zinc. When a single nutrient is lacking, other nutrients are abundant and, in principle, should be able to promote proton influx. The authors should comment about this in the Discussion.

7\) Figures 4G and 4H. FCCP causes cytosolic acidification in 2 min and pH remains almost constant for 30 min. However, Npr1 phosphorylation increases gradually during 30 min of FCCP treatment. How can the authors explain this difference?

8\) Figures 4I and 6K. Npr1 phosphorylation is largely, but not completely, impaired in the *gtr1∆ gtr2∆* strain. The authors should provide an explanation for this residual phosphorylation. This could be discussed.

9\) Subsection "Inhibition of the vacuolar V-ATPase activates TORC1". Optional: Since the authors state that glucose-fermenting cells have a high capacity to buffer the cytosol, how does TORC1 activity respond in respiring cells? This could be discussed.

10\) The authors may wish to discuss their results in light of the recent work demonstrating TORC1 inactivation mediated via assembly into a TOROID (Prouteau M, et al., 2017).

11\) Supplementary data is not always appropriately cited from the main text.

12\) Introduction, second paragraph. \"RhEB\" should be Rheb.

13\) Introduction, third paragraph. TOR was originally identified in yeast in 1991. TORC1 was also identified in yeast, but in 2002 (Loewith R, et al. Mol Cell. 2002; 10(3):457-68).

14\) Introduction, third paragraph. In the genetic nomenclature of *S. cerevisiae*, a dominant allele is denoted by using uppercase italics. Thus, *tor1* should be TOR1.

15\) Introduction, third paragraph. The authors incorrectly refer to TORC1 as \"TORC1 complex\". TORC1 is TOR Complex 1. Thus, it is redundant to write \"TORC1 complex\".

16\) Introduction, third paragraph. The kinase that phosphorylates Rps6 in vivo is not Sch9, but Ypk3 (González A, PLoS One. 2015;10(3):e0120250 and Yerlikaya S, et al. Mol Biol Cell. 2016; 27(2):397-409).

17\) Subsection "Uptake of ß-alanine via the Gap1 permease causes Rag/Gtr-dependent TORC1 activation without increasing internal pools of amino acids". \"CH~3~\" should be corrected to \"CH~2~\" or \"methylene group\".
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Author response

> Summary:
>
> The reviewers agree that the study is a well-designed set of technically sound experiments, with the exception of the quality of some Sch9 immunoblots (see comment 3). The manuscript provides an interesting and unusual explanation on how amino acid sufficiency is transmitted to TORC1 via Gtr1/2 in S. cerevisiae. We have decided to recommend the manuscript for publication in eLife after major revision. Specific comments are as follows.
>
> 1\) The main conclusion of this work, i. e., proton influx coupled to nutrient uptake stimulates TORC1, would be significantly strengthened if the authors performed an experiment expressing (preferably in a gap1∆ background) either of two non-yeast solute transporters that pump the same solute but one as a proton symporter and the other through a different mechanism (sodium symporter, ATP-dependent transporter, etc.) and investigate whether only the proton symporter activates TORC1. Inspiration for such an experimental setup might be taken from Nicklin P, et al. Cell. 2009; 36(3):521-34.

We agree that this is an ideal experiment to strengthen the conclusion that it is the influx of H^+^ that triggers TORC1 activation. This experiment, however, is not easy as transporters from other species are most often poorly active when expressed in yeast. For instance, our first idea was to express in a *gap1 ssy1* mutant, defective in uptake of several amino acids including tryptophan, the human MCT10/TAT1 aromatic amino acid transporter. The group of Fumiyoshi Abe indeed reported that MCT10 expressed in yeast is functional and promotes transport of tryptophan via facilitated diffusion, without the need of an H^+^ gradient across the plasma membrane (Uemera et al. BBA vol. 1859, pp. 2076-2085). Dr. Abe kindly sent us a plasmid for expression of MCT10/TAT1 in yeast and we introduced it into the *gap1 ssy1* mutant. However, MCT10/TAT1 was unable to restore growth on aromatic amino acids as sole nitrogen source, indicating that it is not functional (as growth tests are indeed highly sensitive to detect amino-acid permease activities).

We thus reasoned that it is preferable to compare cells *endogenously* expressing a facilitator or an H^+^-coupled transporter, both recognizing the same compound. Hexoses including fructose are known to be transported into yeast cells via facilitators, namely the Hxt proteins. We contacted our colleague Eckhard Boles who drew our attention on the fact that particular strains of *S. cerevisiae* express an H^+^-coupled fructose transporter termed Fsy1. Dr. Paula Gonçalves (Lisbon) who reported this interesting finding kindly sent us strains and plasmids to express Fsy1 in the *hxt* null strain (EBY.VW4000) lacking the *HXT1 to -17* and *GAL2* genes, and thus unable to use glucose or fructose as a carbon source. We thus compared cells of the *hxt* null mutant expressing or not Fsy1. As a control, we used the wild-type CEN.PK2-1c strain (from which EBY.VW4000 derives) expressing the endogenous Hxt facilitators. The strains were first grown on maltose (they can use this carbon source as they still possess their maltose permease genes) and then shifted for a few hours on ethanol, because the *FSY1* gene is more highly expressed on ethanol (Rodrigues de Sousa et al., 2010). As in all other experiments, the nitrogen source was proline. Using these growth conditions, we then set up conditions of equivalent ^14^C-fructose uptake in Hxt- and Fsy1-expressing cells. As expected, no significant uptake was detected in the *hxt* null strain. Furthermore, we could nicely confirm that fructose uptake via Fsy1 is inhibited if cells are pretreated with FCCP, this being not the case when this uptake is mediated by the Hxt facilitators. We finally applied these growth and fructose uptake conditions to assay TORC1 activation using Sch9 phosphorylation as a readout. We observed a rapamycin-sensitive increased phosphorylation of Sch9, upon fructose uptake, in Fsy1-expressing cells. Such an activation of TORC1 was not detected in the wild-type incorporating fructose via the Hxt facilitators neither the *hxt* null strain expressing none fructose transporter. These results have now been included as Figures 4G, H, Iandare described in the last paragraph of the subsection "H^+^ influx coupled to transport promotes Rag/Gtr-dependent stimulation of TORC1".

One comment must be added. The result of this experiment could seem surprising as previous studies reported that addition of glucose (entering cells via Hxt facilitators) to glucose-starved cells reactivates TORC1, assayed also using Sch9 phosphorylation as a readout. These experimental conditions, however, are different from the ones we have applied as we grew cells on maltose and transferred them to ethanol, two carbon sources cells can utilize. In these cells, Pma1 remained active as we could detect an FCCP-sensitive fructose uptake via Fsy1. This markedly contrasts with glucose-starved cells where Pma1 is inhibited and the H^+^ gradient at the plasma membrane collapses (see i. e., Figure 4A, 4B). Furthermore, when glucose is provided to glucose-starved cells, Pma1 is rapidly reactivated and this should promote H^+^-coupled uptake of nutrients including amino acids. This H^+^-coupled uptake could contribute to the glucose-elicited reactivation of TORC1. A comment emphasizing this point has also been included in Discussion (second paragraph).

We have tried to also use HA-Npr1 phosphorylation as a readout of TORC1 activation in response to fructose uptake. We were faced to unexpected difficulties that seem to originate from the fact that under the particular carbon supply conditions used in the experiment, Npr1 undergoes a high basal of phosphorylation largely resistant to rapamycin (data not shown). We have not further investigated this effect (because of a lack of time) and decided to focus on Sch9.

We thank the reviewers for their excellent suggestion as we think that this experiment strongly strengthens the main conclusion of our work, namely that H^+^ influx coupled to nutrient uptake is a signal for transient TORC1 activation in yeast.

> 2\) It is unclear which amino acids require Pma1 to activate TORC1 and which do not. This can be addressed experimentally. The authors should monitor TORC1 activity over time (with emphasis on the early time points) in ScPma1 and (Np)Pma4^822ochre^ expressing cells in response to different amino acids such as leucine (activates TORC1 via Gtr1/2) or glutamine (activates TORC1 also independently of Gtr1/2). They should ideally use gtr1∆gtr2∆ cells as a control.

We set up conditions of equivalent initial uptake of Gln, Leu and Arg in the *(Sc)PMA1*- and *(Np)PMA4^822ochre^*-expressing cells (rem: for Arg, uptake was equivalent at least during the first 4 minutes). We then applied these conditions to analyze TORC1 activation using HA-Npr1 phosphorylation as a readout. The result showed that uptake of Gln, Leu or Arg stimulates TORC1 in (Sc)Pma1 cells (unless rapamycin was present), but not in the (Np)Pma4^822ochre^ cells. We additionally analyzed the influence of the *gtr1Δ gtr2Δ* mutations, as requested. None significant increased phosphorylation of HA-Npr1 phosphorylation was detected upon addition of Leu, Gln or Arg to the *gtr1Δ gtr2Δ* strain. These results thus support our conclusion that Pma1 plays an important role in Rag/Gtr-dependent TORC1 activation in response to amino-acid uptake. They have been included as Figure 7---figure supplement 2 in the revised version of our article (Figure 7 is former Figure 6). We describe them in the second paragraph of the subsection "TORC1 activation in response to increased cytosolic H^+^ requires the Pma1 H^+^ ATPase".

> 3\) Figures 1E, 5C, 5G, Figure 7---figure supplement 1B and Figure 1---figure supplement 2. Total Sch9 levels are not controlled properly. Figure 1---figure supplement 2 shows that the antiserum against dephosphorylated Sch9 is sensitive to phosphorylation. Sch9 immunoblots should be repeated with better reagents.

All indicated immunoblots have been either hybridized again, or the full experiment repeated, using an antibody against Sch9 (kindly provided by Dr. R. Loewith) that is not sensitive to phosphorylation. Furthermore, we decided to repeat the experiments for Figures 3C, 4D, 4J (now Figure 5C), 5C (now Figure 6C) and 5G (now Figure 6G) using the better-quality antibody. The latter was also used for Figure 6G (now Figure 7G). All obtained data fitted with our expectation and now appear in the revised version of our article.

> 4\) The authors should determine whether Pib2 or SEACIT/SEACAT components are necessary for proton influx/Pma1 to activate TORC1. Gtr1/2 and Pib2 are believed to function independently, but the evidence does not rule out dependencies. Also, the SEACAT and SEACIT complexes regulate Gtr1/2 and TORC1. Single knockout mutants could be generated and analyzed.

We introduced in the strain background used in our study (Σ1278b) a deletion of the *PIB2, IML1* (SEACIT), and *SEH1* (SEACAT)genes. We then analyzed H^+^-influx-elicited TORC1 activation using FCCP as a trigger and HA-Npr1 phosphorylation as a readout. The results showed that:

\- Pib2 is not essential to H^+^-influx-elicited TORC1 stimulation.

\- In the *ilm1Δ* mutant, HA-Npr1 displayed a high basal phosphorylation, as expected. Addition of FCCP further increased HA-Npr1 phosphorylation but only after a long incubation time (30 min). This phenotype is similar to the one observed in the *gtr1Δ gtr2Δ* mutant (see new Figure 5D) and show that FCCP also promotes a late TORC1 activation in a manner independent on the Gtr1/2 GTPases and their upstream regulators. This particular point, namely the existence of a late, Gtr-independent, activation of TORC1 upon FCCP addition, has also been raised in comments 7 and 8 (see below our responses).

\- In the *seh1Δ* mutant, FCCP-elicited activation of TORC1 was impaired, at least during the early minutes after FCCP addition. We also noticed that the intensity of the HA-Npr1 signal is much weaker in this strain. This effect was also observed (though less pronounced) in the *gtr1Δ gtr2Δ* (see i.e., Figures 1G, 4E, and new 5D) and *tco89Δ* (our unpublished data) mutants, but its cause remains unclear. It in fact suggests that HA-Npr1 is less abundant when TORC1 is poorly active. Again, addition of FCCP to this strain further increased HA-Npr1 phosphorylation but only after a long incubation time (30 min), as in the *gtr1Δ gtr2Δ* mutant (see comments 7 and 8 below).

In conclusion, Pib2 is not involved in TORC1 activation in response to H^+^-influx. In contrast, components of the SEACAT and SEACIT complexes seem to play an important role in this activation. Overall these results support the proposed view that TORC1 activation in response to H^+^ influx requires the Rag/Gtr GTPases and their SEAC upstream regulators. Pib2, however, already known to act independently of the Gtr1/2, is not essential to this TORC1 activation pathway. These additional results now appear as Figures 5E, 5F, and 5G in the revised version of our article. They are commented on in the second paragraph of the subsection "H^+^ diffusion via a protonophore promotes Rag/Gtr-dependent stimulation of TORC1".

> 5\) The role of Pma1 in TORC1 activation is intriguing. The use of a separation of function allele of Pma1 that loses the ability to signal to TORC1 would be a good complement to this work. Perhaps a screen for viable Pma1 alleles that present an EGO phenotype (i.e., fail to recover from rapamycin growth arrest) could yield such an allele. This would not be a make-or-break issue for publication but a suggestion to improve the manuscript.

We agree that such allele would beautifully complement our data suggesting a potential regulatory function of Pma1 in TORC1 activation in response to H^+^ influx. We thus generated a library of random *pma1* mutants and, after transformation into the *GAL-PMA1 pma2* strain, we tried to positively select on a glucose medium colonies exhibiting increased resistance to rapamycin. We thus tried to isolate Pma1 variants hyperstimulating TORC1. Our first attempts failed: we\'ve obtained resistant clones, but not more than after transformation with a non-mutagenized *PMA1* gene. However, we are not 100% sure that our positive selection method was suited (quality of the library, selection conditions, ...). We decided to temporarily put on hold this experiment (because of lack of time) and decided to invest in another approach.

We indeed found in the literature a very interesting article series showing that the Na^+^/K^+^-ATPase of animals cells, similar in sequence to the yeast Pma1 (both belong to the same P-type ATPase structural family), has signaling capabilities. Namely, the Na^+^/K^+^-ATPase is an inhibitor of the Src kinase, and binding of cardiotonic steroids such as ouabain to the Na^+^/K^+^-ATPase relieves this inhibition. Remarkably, the group of Zijian XIE identified a cytosolic region in the Na^+^/K^+^-ATPase which when mutated provoked a loss of interaction with Src, without affecting the catalytic activity of the ATPase (Lai et al., 2013). We found very interesting the observation that when the sequences of Pma1 and the Na^+^/K^+^-ATPase were aligned, this particular region appeared well conserved in Pma1. We thus generated several Pma1 mutants harboring substitutions in the depicted sequence, expressed them in the *GAL-pma1 pma2* mutant, and tested their functionality. These substitutions were: A408P, A411P, A411P+A604V, R414A, and C409A+L410A+R414A. Unfortunately, this approach did not lead to any relevant result: Pma1(A408P) turned out to be nonfunctional, and we did not observe any TORC1 activation defect in response to FCCP in cells expressing the other Pma1 mutants (data not shown).

We hope that the reviewers will appreciate that we did our best to also address this point. For the revised version of our article, we propose (i) to include a comment in Discussion about the illustrated role of the Na^+^/K^+^-ATPase in signaling (ii) to mention that we have tried to introduce into Pma1 substitutions in a similar region, but that these did not impair TORC1 activation (lines 592-602). We think that this comment will emphasize that although it seems reasonable to propose a model whereby Pma1 signals to TORC1 (given the properties of the Na^+^/K^+^-ATPase), it is far from being demonstrated and requires further investigation.

> 6\) It is known that TORC1 is inactivated when cells are starved for a single amino acid such as leucine (in the case of leu2∆ cells) or for phosphate, sulfate or zinc. When a single nutrient is lacking, other nutrients are abundant and, in principle, should be able to promote proton influx. The authors should comment about this in the Discussion.

We think that two aspects must be considered to explain this apparent paradox. First, reduction of TORC1 activity in cells starved for a single nutrient is probably due to control mechanisms capable of sensing the nutritional status of the cell, and not just to a potential drop of its H^+^-coupled uptake. Consistently, addition to these cells of the limiting nutrient leads to its H^+^-coupled uptake associated with a transient reactivation of TORC1, but more sustained TORC1 activity requires proper assimilation of the nutrient by the cells. Second, it is likely that the drop of TORC1 activity caused by a single starvation not only promotes derepression of high-affinity permeases for the limiting nutrient, but also accelerated endocytosis of the permeases for the non-limiting nutrients. It is indeed known that inhibition of TORC1 by rapamycin promotes endocytosis of many different permeases. This general control is likely associated with a global drop of H^+^ influx that could also contribute to the reduction of TORC1 activity despite the abundance of other nutrients in the medium. These two aspects have now been better emphasized in the Discussion of the revised version of our article (second paragraph).

> 7\) Figures 4G and 4H. FCCP causes cytosolic acidification in 2 min and pH remains almost constant for 30 min. However, Npr1 phosphorylation increases gradually during 30 min of FCCP treatment. How can the authors explain this difference?

It is true that HA-Npr1 phosphorylation further increases after a long incubation in the presence of FCCP (Figure 4H, now Figure 5B). This apparent late activation of TORC1 was also detected in the *gtr1Δ gtr2Δ* strain and in mutants lacking SEACIT or SEACAT upstream regulators of Gtr1/2 (see comment 4 above). Our interpretation is that a longer treatment of cells with FCCP stimulates another TORC1 activation mechanism that is not dependent on the Gtr1/2 GTPases neither their upstream regulators. This is reminiscent of the previous observation by M. Hall and collaborators (Stracka et al., 2014). One possibility is that this late activation of TORC1 is due to FCCP-induced release of amino acids or other compounds stored in the vacuole or mitochondria. This tentative interpretation has now been included in the revised version of the article (subsection "H^+^ diffusion via a protonophore promotes Rag/Gtr-dependent stimulation of TORC1", second paragraph).

> 8\) Figures 4I and 6K. Npr1 phosphorylation is largely, but not completely, impaired in the gtr1∆ gtr2∆ strain. The authors should provide an explanation for this residual phosphorylation. This could be discussed.

Figure 4I (now Figure 5D): as discussed above, we now propose in the text (subsection "H^+^ diffusion via a protonophore promotes Rag/Gtr-dependent stimulation of TORC1", second paragraph) that this Gtr1/2-independent activation of TORC1 might be promoted by amino acids released from the vacuole or mitochondria.

Figure 6K (now Figure 7K): that phosphorylation of HA-Npr1 in response to NH~4~^+^ is not impaired in the *gtr1Δ gtr2Δ* strain is expected and consistent with the previous work of Stracka et al. (2014). We think that this was clearly mentioned in the text and does not need to be further emphasized. The interesting result of this experiment is that Pma1 does not play an important role in a TORC1 activation pathway known to be independent on the Gtr1/2 GTPases.

> 9\) Subsection "Inhibition of the vacuolar V-ATPase activates TORC1". Optional: Since the authors state that glucose-fermenting cells have a high capacity to buffer the cytosol, how does TORC1 activity respond in respiring cells? This could be discussed.

We could at least show that in cells shifted for six hours on ethanol, TORC1 is activated in response to H^+^-coupled fructose uptake but not passive fructose transport (see point 1). This observation suggests that the activity of TORC1 is also stimulated by H^+^ influx in respiring cells, but this question probably needs further investigation beyond the scope of our article.

> 10\) The authors may wish to discuss their results in light of the recent work demonstrating TORC1 inactivation mediated via assembly into a TOROID (Prouteau M, et al., 2017).

This reference and a comment have now been included in the text (Discussion, sixth paragraph).

> 11\) Supplementary data is not always appropriately cited from the main text.

This has now been corrected.

> 12\) Introduction, second paragraph. \"RhEB\" should be Rheb.

This has now been corrected.

> 13\) Introduction, third paragraph. TOR was originally identified in yeast in 1991. TORC1 was also identified in yeast, but in 2002 (Loewith R, et al. Mol Cell. 2002; 10(3):457-68).

This has now been corrected.

> 14\) Introduction, third paragraph. In the genetic nomenclature of S. cerevisiae, a dominant allele is denoted by using uppercase italics. Thus, tor1 should be TOR1.

This has now been corrected.

> 15\) Introduction, third paragraph. The authors incorrectly refer to TORC1 as \"TORC1 complex\". TORC1 is TOR Complex 1. Thus, it is redundant to write \"TORC1 complex\".

This has now been corrected.

*16) Introduction, third paragraph. The kinase that phosphorylates Rps6* in vivo *is not* Sch9*, but Ypk3 (González A, PLoS One. 2015;10(*3*):e0120250 and Yerlikaya S, et al. Mol Biol Cell. 2016; 27(*2*):397-409).*

This has now been corrected.

> 17\) Subsection "Uptake of ß-alanine via the Gap1 permease causes Rag/Gtr-dependent TORC1 activation without increasing internal pools of amino acids". \"CH~3~\" should be corrected to \"CH~2~\" or \"methylene group\".

This has now been corrected.

[^1]: These authors contributed equally to this work.
